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1,3-β-glucans are extracellular polysaccharides synthesized by microorganisms and 
plants, with therapeutic potential. Among them, the O2-substituted-(1–3)-β-D-glucan, 
synthesized by some lactic acid bacteria (LAB), has a prebiotic effect on probiotic strains, 
an immunomodulatory effect on monocyte-derived macrophages, and potentiates the 
ability of the producer strain to adhere to Caco-2 cells differentiated to enterocytes. In 
this work, the O2-substituted-(1–3)-β-D-glucan polymers produced by GTF 
glycoyltransferase in the natural host Pediococcus parvulus 2.6 and in the recombinant 
strain Lactococcus lactis NZ9000[pNGTF] were tested. Their immunomodulatory activity 
was investigated in an ex vivo model using human biopsies from patients affected by 
Crohn’s disease (CD). Both polymers had an anti-inflammatory effect including, a reduction 
of Interleukine 8 both at the level of its gene expression and its secreted levels. The overall 
data indicate that the O2-substituted-(1–3)-β-D-glucan have a potential role in ameliorating 
inflammation via the gut immune system cell modulation.
Keywords: bacterial exopolysaccharides, O2-substituted-(1-3)-β-D-glucan, lactic acid bacteria, 
Immunomodulation, Crohn´s disease anti-inflammatory effect
INTRODUCTION
The exopolysaccharides (EPS) are large, lineal, or branched, extracellular carbohydrate polymers, 
produced by algae, plants, and bacteria. They are commonly used as food additive due to 
their rheological properties (bio-thickener, gelling, or viscosifier agents) in the food industry. 
The demand for new polymers in the food industry is positioning EPS from lactic acid bacteria 
(LAB), as the new generation of food thickeners. Due to their Generally Regarded As Safe 
(GRAS) status, they are suitable for the production of fermented and/or functional products. 
The EPS synthesized by LAB are divided into homopolysaccharides, if they contain only one 
monosaccharide type or heteropolysaccharides, if they contain various monosaccharides types 
(Werning et  al., 2012). These EPS are known to support bacterial growth, as well as participate 
Notararigo et al. Immunomodulatory Effect of Bacterial β-Glucan
Frontiers in Microbiology | www.frontiersin.org 2 February 2021 | Volume 12 | Article 621280
in cellular recognition and interaction, surface adhesion, and 
biofilm formation. Currently, EPS are gaining interest as 
prebiotics, as modulators of the host immune system (Schmid 
et  al., 2015), and as antiviral agents (Nácher-Vázquez et  al., 
2015). Their immunomodulatory properties are dependent on 
their ability to form a suitable tertiary structure. For instance, 
(1–3)-β-D-glucans (β-glucans), linear or branched in position 
O-4 and O-6, are gaining interest as therapeutic targets; various 
studies have shown their positive influence in reduction of 
human serum cholesterol levels and their stimulation of the 
human immune system (Chan et  al., 2009; Jin et  al., 2018), 
as well as their potential anti-carcinogenic properties (Chan 
et  al., 2009; Ali et  al., 2015).
Recent findings documented that (1–3)-β-glucans are capable 
of regulating the inflammatory response, modulate immune 
system cell types (such as peripheral blood immune system 
cells, intestinal epithelium, and mammalian microglia), through 
their interaction with membrane receptors, including toll-like 
receptors, Dectin-1, SIGNR1, complement receptor 3 (CR3), 
LaCer, and Scavenger, which are differentially expressed in 
these cells types (Li et  al., 2019). Their interaction with a 
receptor leads to downstream events including the activation 
of immune system cells, both innate (e.g., macrophages, 
monocytes, or neutrophils) and adaptive (e.g., T cells or B 
cells). These interactions may result in differential cytokine 
production [such as tumor necrosis factor-α (TNF-α), IL-10, 
IL-8, or IL-12], through the modulation of the nuclear factor 
kappa-light-chain-enhancer of activate B cells (NFκB) 
transcription factor, belonging to the mitogen-activated protein 
kinase (MAPK) pathway (Chan et al., 2009; Volman et al., 2010).
Moreover, it has been reported that the EPS are metabolized 
in the gut due to the presence of the glycolytic enzyme pools 
of the microbiota. The exact nature of this process depends on 
the molecular weight and biochemical composition of the EPS 
(Bodera, 2008; Kau et  al., 2011; Ballesteros Pomar and Gonzalez 
Arnaiz, 2018). Finally, this hydrolysis is beneficial to both the 
host and the microbiota itself, because it generates secondary 
metabolites with the potential to act as probiotic or postbiotic 
immunomodulators, that ultimately promote and/or restore a 
healthy environment for the microbiota (Iweala and Nagler, 2019). 
Laminarin, an O6-substituted-(1–3)-β-D-glucan isolated from 
brown algae, causes a reduction in the expression of 
pro-inflammatory cytokines, such as IL-6 and IL-1β in pig 
intestinal mucosa (Heim et  al., 2014; Walsh et  al., 2015) and 
counteracts dysbiosis of the microbiota (Rattigan et  al., 2020). 
Moreover, studies performed with human fecal microbiota and 
commercial laminarin from Laminaria digitata, or crude 
polysaccharide-rich extracts from this algae, indicated that the 
polysaccharide influences mucus and gut microbiota composition, 
which results in a potentially beneficial production of short-chain 
fatty acids (such as butyrate; Devillé et al., 2007; Strain et al., 2020).
Inflammatory bowel disease (IBD) has a multifactorial etiology 
and includes Crohn’s disease (CD) and ulcerative colitis (UC; 
Kamada et  al., 2013; Morhardt et  al., 2019). They are chronic 
gastrointestinal disorders, where the dysregulation of the immune 
system is responsible for immunological imbalance characterized 
by the production of pro-inflammatory cytokines (such as 
TNF-α, INF-γ, IL-17, and IL12) into the gut lumen, alteration 
of microbiota, and the intestinal mucosal barrier (Knights et al., 
2013). High inflammation is responsible for abdominal pain, 
bloody stools, weight loss, diarrhea, etc.
To evaluate therapeutic treatments, current chemically induced 
animal models of IBD, including sodium dextran-sulfate 
treatment, resembles UC symptoms, but emulates only partially 
the inflammatory process that occurs in human CD (Chassaing 
et  al., 2014). However, an ex vivo model, using CD mucosal 
tissue, allows the investigation of how to modulate the 
inflammation at the gut mucosa level. Previous studies, using 
this model, have established that certain probiotic bacteria are 
capable of interacting with immunocompetent cells using the 
mucosal interface, and thus can modulate locally the production 
of pro-inflammatory cytokines by inflamed tissue (Borruel 
et al., 2003; Llopis et al., 2009; Hidalgo-Cantabrana et al., 2015).
In this context, recently, new therapeutic strategies involving 
the use of probiotic strains have been developed to ameliorate 
CD patient’s symptoms. Some of these include microorganisms, 
such as Lacticaseibacillus rhamnosus GG, Limosilactobacillus 
reuteri, Lactobacillus acidophilus, Bifidobacterium infantis, 
Saccharomyces boulardii, Escherichia coli Nissle 1917, and 
Clostridium butyricum MIYAIRI 588 (Tsai et  al., 2019), which 
contribute to reduction of inflammation, due to their ability 
to reduce pathogen adhesion to the intestinal epithelium (blocking 
their binding site), and by production of antibacterial substances 
or EPS (Orel and Kamhi Trop, 2014; Oka and Sartor, 2020). 
In addition, probiotic strains modify the release of cytokines 
in the intestinal epithelium and inhibit, in the immune system 
cells, the production of the transcription factor NFkB, leading 
as a consequence to a reduction of intestinal inflammation 
(Basson et  al., 2017; Oka and Sartor, 2020). In this general 
context, some probiotic bacteria produce a O2-substituted-
(1–3)-β-D-glucan with prebiotic activity and that stimulate the 
growth of probiotic LAB (Russo et  al., 2011; Pérez-Ramos 
et  al., 2017). Therefore, the producing bacteria or their EPS 
have potential as adjuvants in the treatment of IBD. Such a 
role is plausible, taking into account that β-glucans play an 
important role in the modulation of both the innate immune 
response, through interaction with dendritic cells (DCs) and 
macrophages, and also in the adaptive immune response, 
increasing proliferation of T- and natural killer cells, via cytokine 
release (Bodera, 2008; Zhang et  al., 2015).
Only Pediococcus, Lactobacilli, and Oenococcus strains isolated 
from alcoholic beverages synthesize the O2-substituted-(1–3)-
β-D-glucan (reviewed in Llamas-Arriba et al., 2019). Moreover, 
studies performed with Pediococcus parvulus 2.6 isolated from 
cider and with the recombinant L. lactis NZ9000[pGTF] strain 
carrying the pediococcal gtf gene, demonstrated that this gene 
encodes the GTF glycosyltransferase, which catalyzes the 
synthesis of the O2-substituted-(1–3)-β-D-glucan in LAB 
(Werning et  al., 2006, 2008, 2012). Moreover, P. parvulus 2.6 
and L. lactis NZ9000[pGTF] synthesize, respectively the EPS 
P and the EPS L polymers having the same primary structure, 
which is different from those of the β-glucans isolated from 
fungi and yeasts, which have ramifications at positions O-4 
and O-6 (Thompson et  al., 2010).
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This peculiarity of structure was the reason why we investigated 
the probiotic potential of the producing strain P. parvulus 2.6 
(Werning et  al., 2012; Pérez-Ramos et  al., 2017), and the 
prebiotic potential of its EPS P (Russo et  al., 2011; Pérez-
Ramos et  al., 2017). Also, our previous work supports an 
anti-inflammatory effect of this O2-substituted-(1–3)-β-D-glucan. 
Comparison of the behavior of P. parvulus 2.6 with its isogenic 
EPS P-non-producing strain, revealed that the presence of the 
polymer decreased the pro-inflammatory effect exerted by the 
LAB on human macrophages M1, indicating a possible activity 
of this EPS as an immunomodulator in the innate immune 
response (Fernández de Palencia et  al., 2009). Moreover, in 
an induced inflammation model, using the zebrafish transgenic 
line Tg(mpx:GFP)i114, the polymer inhibited neutrophil 
recruitment and proliferation in the larvae, confirming once 
again its potential as an immunomodulator (Pérez-Ramos et al., 
2018). Furthermore, the metabolic rate of macrophages derived 
from human monocytes increased upon exposure to either 
the EPS P and the EPS L synthesized by L. lactis NZ9000[pGTF] 
(Notararigo et  al., 2014). In addition, these EPS activated 
processes involved in M1 differentiation, migration, and cellular 
proliferation, as well as inhibited AKT and mTor pathways 
implicated in the inflammatory response (Notararigo et  al., 
2014). Therefore, this current work aimed to study the 
immunomodulatory effect of the O2-substituted-(1–3)-β-D-
glucan, vs. the O6-substituted-(1–3)-β-D-glucan, (laminarin, 




Samples of intestinal mucosa were obtained during surgery 
from four patients with CD (one male and three females, age 
46.7  ±  19.9, SEM), who underwent ileal resection for stricture 
unresponsive to conventional medical treatment (Table  1). 
Biopsies of the intestinal tissue were kept at 4°C, from collection 
until their later handling. None of the patients had been on 
anti-TNF treatment for at least 2 months before the intervention.
The diagnosis of CD was previously established by the 
clinical routine, as well as radiological and endoscopic, criteria, 
and afterwards was confirmed by histological evaluation of 
the surgical specimen. All patients received the same preparation 
for colonic surgery including gut lavage with electrolyte-
polyethylene glycol solution and broad-spectrum antibiotic 
therapy.
The study was approved by the Ethics Committee (Comité 
Ético de Investigación Clínica, Hospital Vall d’Hebron, Barcelona). 
Written informed consent was obtained from all patients [CEIC: 
PR(AG)56/2010].
EPS P and EPS L Production and 
Purification
Exponential cultures of P. parvulus 2.6 (Dueñas-Chasco et  al., 
1997; Pérez-Ramos et  al., 2018) and L. lactis NZ9000[pGTF] 
(Werning et  al., 2008) were used to produce EPS P and EPS L, 
respectively. The EPS were produced and purified, as previously 
described (Notararigo et  al., 2013). Briefly, after removal of 
bacterial cells by centrifugation, the EPS present in the culture 
supernatants were precipitated with three volumes of ethanol. 
Then, the EPS were further purified by dialysis and fractionation 
by size exclusion chromatography after resuspension in a 0.3 M 
NaOH solution. Afterwards, the EPS alkaline solution was 
dialyzed as above. Finally, the EPS was lyophilized and left at 
room temperature until use. After the first and second 
lyophilization, the purity of the EPS was tested fluorometrically 
using specific fluorescent staining kits for DNA, RNA, and 
proteins as previously reported (Zarour et  al., 2018). Solutions 
of the purified polymers were prepared at 1  mg ml−1. No 
contaminants were detected (Table  2).
Organ Culture of Human Colonic Mucosa
Organ culture assays were performed as described (Borruel 
et  al., 2002, 2003; Llopis et  al., 2009). Full-thickness ileal wall 
specimens, including areas with macroscopic lesions, were 
collected at surgery. After rinsing and washing with sterile 
saline solution, the specimens were transferred to the laboratory 
in sterile saline solution at 4°C. The intestinal mucosa was 
removed from the tissue, and cut into pieces of approximately 
25–35  mg weight each, making an equal distribution of the 
macroscopic lesion. Each piece was placed on the insert of a 
12-well cell culture plate (Netwell culture system, Costar), with 
the epithelial surface uppermost. Filters were placed into the 
wells and incubated with 1,500  μl RPMI 1640 culture medium 
(CanSera), without antibiotic (37°C, 95% O2, 5% CO2 -carbogene-). 
Before usage, the culture medium was filtered through a 0.22 μm 
membrane, warmed to 37°C, and gassed for 90  min with 
carbogen. Tissue without lesion (not inflamed) was used as 
negative control.
The tissues obtained from biopsies of CD patients were 
exposed independently to EPS L, EPS P, or laminarin. A solution 
of the polymers in culture medium at 100  μg ml−1 was added 
by dripping onto the tissues. The cell culture plate was covered 
TABLE 1 | Characteristics of the patients included in the pilot study.
Patients Age Sex Affected 
segment
Debut date Treatment
1 20 F Ileocecal 2 years Azathioprine + budesonide
2 42 F Ileocecal less than 
6 months
Amoxicillin + clavulanate
3 57 F Ileocecal 8 years Mesalazine + azathioprine
4 68 M Ileocecal 28 years Azathioprine
TABLE 2 | Detection of contaminants in EPS preparations.
Contaminants
1 lyophilization 2 lyophilization
EPS P EPS L EPS P EPS L
DNA (%) 0 0 0 0
RNA (%) 0 <0.1 0 0
Proteins (%) <0.1 1.2 0 0
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with a supported lid, allowing a correct exchange of gases, 
and subsequently placed in a bath at 37°C, inside a container 
shielded with a wet cloth. Then, the container was connected 
to the carbogen gas outlet, gassed at high pressure for 10  s 
at 1  h intervals, and incubated for 4  h.
Then, the pro-inflammatory (TNF-α and IL-8) and anti-
inflammatory (IL-10) cytokine levels released into the media 
were quantified by ELISA. At the end of the experiment, 
aliquots of the supernatant were collected from each well, prior 
to being stored at −80°C, while the tissue was kept immersed 
in 400 μl of rRNA stabilization solution “RNA later” (Ambion) 
at 4°C overnight, and then stored at −80°C.
Determination of Cytokine Levels by Elisa
The cytokine protein profiles of tissue culture supernatants, in 
response to EPS treatments, were analyzed by OptEIA ELISA 
(BD Pharmingen) to detect IL-10 and TNF-α, as well as by DuoSet 
ELISA (RD Systems) for IL-8, following the suppliers’ instructions.
The cytokine concentrations were extrapolated from the 
regression line generated using the absorbance values of a 
standard curve, which was produced in the same test with 
known concentrations of commercial cytokines.
Gene Expression Profiling Under EPS 
Treatment
In gene expression organ culture assays, CD samples were 
harvested in the presence of RNA later (Ambion) and stored 
at −80°C. RNA extraction from the patients’ biopsies was 
performed using the RNeasy mini (Qiagen), according to the 
supplier’s instructions. RNA concentration and integrity were 
analyzed and determined with the RNA 6000 Nano Chip in 
a Bioanalyzer 2100 (Agilent Technologies). RNA quantity and 
integrity were considered acceptable if the 28S/18S ribosomal 
fragment ratio was over 1.5, and the RNA Integrity Number 
(RIN) ranged in values between 9 and 10. Selected gene 
expression was evaluated with real-time PCR, and 1  μg of 
total RNA was used for the reverse transcription to synthesize 
first strand cDNA following the recommended protocol of the 
High-Capacity cDNA Reverse Transcription kit (Applied 
Biosystems). Quantitative PCR was then carried out with the 
Taqman Gene Expression Assay (Thermo fisher Scientific), using 
TaqMan Fast Universal PCR Master Mix (2X; Applied Biosystems). 
Relative quantification of gene expression of thymic stomal 
lymphopietin (TSLP), IL-12p35, IL-10, and IL-8 was determined, 
using a 7500 Fast Real time PCR System (Applied Biosystems). 
Data were obtained as threshold cycle (Ct) values. Gene expression 
levels for each individual sample were normalized relative to 
the PPIA gene as housekeeping/constitutive/endogenous gene, 
which encodes the Peptidylprolyl Isomerase A (also called 
Cyclophilin A). Each condition was run in triplicate.
Transcription Factor Signaling Pathways 
NFκB RNA Array
The RT2Profiler PCR array (SABiosciences-Qiagen) was used 
to obtain the expression profile of 84 fundamental genes of the 
NFκB pathway (Supplementary Table S1; supplementary data).
The analysis with the array was performed according to 
the manufacturer’s instructions, as follows. The substrate used 
was cDNA synthesized from RNA samples (obtained from 
patient biopsies) with the “RT2 First Strand” kit (Qiagen). The 
quantitative-RT-PCR (qPCR) was carried out using the SYBR 
GREEN technology “RT2 SYBR Green,” and run in a thermal 
cycler iQ5 (BioRad). Once the reaction was complete, the data 
corresponding to the Ct values of each gene were exported 
to a data sheet for further analysis. The analysis of the differential 
gene expression was carried out through the web application 
developed by the company for this purpose based on the 
method ΔΔCt and using three of the five constitutive genes 
for the standardization of the data (β-actine, β-2-microglobulin, 
and the ribosomal P0 protein; Seeger et  al., 2014).
Bioinformatic Functional Analysis
The functional analysis of the selected genes was performed 
using the Database for Annotation, Visualization and Integrated 
Discovery (DAVID 6.7; http://david.abcc.ncifcrf.gov), which 
integrates the information of over 1.5  million genes in more 
than 65.000 species, from different public sources of gene and 
protein notations (Huang et  al., 2008). DAVID provides a 
functional classification of genes by extracting the information 
from various databases. We selected terms from Gene Ontology 
(GO; http://geneontology.org/) and from molecular pathways 
integrated in: the Biological Biochemistry Image Database (BBID, 
http://bbid.irp.nia.nih.gov/), Biocarta (http://www.biocarta.com/
genes/index.asp), and the Kyoto Encyclopedia of Genes and 
Genomes (KEGG, http://www.genome.jp/kegg/).
Gene ontology terms allows the unification of the 
representation of the attributes of genes and their products 
among the species, favoring the functional interpretation of 
experimental data by dividing the terms into three categories: 
cellular compartment (CC), molecular function (MF), and 
biological process (BP). The use of molecular pathways databases 
facilitates the production of graphic information of how genes 
and their products interact.
Statistical Analysis
Statistical analysis was carried out using the Prism 8 (GraphPad) 
software. The normality of the data was tested by the Kolmorov-
Smirnov or Shapiro-Wilk Test normality test. For parametric 
data, a two-tailed paired t-test was applied, while for 
nonparametric data, the Friedman Test for paired data was used.
For qPCR, for parametric data, unpaired two-tailed Student 
t-test was performed with Welch’s correction. Values with 
p  <  0.05 were considered significant.
RESULTS AND DISCUSSION
Effect of O2-Substituted-(1–3)-β-D-Glucans 
on Cytokine Production in ex vivo Models
The EPS P and EPS L synthesized by P. parvulus 2.6 and 
L. lactis NZ9000[pGTF], respectively, are identical O2- 
substituted-(1–3)-β-D-glucans with the same primary structure 
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(Dueñas-Chasco et  al., 1997; Werning et  al., 2014). However, 
the polymers have different molecular masses, 9.6  ×  106  Da 
for EPS P and 6.6  ×  106  Da for EPS L (Werning et  al., 2014). 
The molecular mass of polysaccharides plays a role in their 
biological activity, consequently, there may be differences between 
the immunomodulatory activities of each EPS, and therefore 
both polymers were tested. Thus, in the present pilot study, 
to evaluate EPS P and EPS L (Figure  1A), ex vivo tissue 
cultures have been used as a model of pathological intestinal 
inflammation (Figure  1B), in which the immune system plays 
an important role in the development, propagation, and 
maintenance of inflammation and disease. We  have shown 
that this model is suitable to investigate the effects of LAB 
treatment on the intestinal immunity axis (Bäuerl et  al., 2013). 
Laminarin was also tested as a positive control due to its 
ability to activate the immune system through its interaction 
with the Dectin-1 receptor (Xie et al., 2010; Smith et al., 2018).
Tissues obtained from biopsies of four CD patients were 
exposed independently to the polysaccharides (Figure 1B); and 
subsequently the pro-inflammatory (TNF-α and IL-8) and anti-
inflammatory (IL-10) cytokine levels released into the media 
were quantified (Figure  1C). The results revealed that the 
concentration of the pro-inflammatory IL-8 secreted by the 
tissues during treatment with either of the three β-glucans 
tested was significantly lower (p  <  0.05) than that released by 
the untreated control tissue. In addition, the highest effect 
was obtained with EPS P or laminarin. These results indicated 
a role of the O2-substituted-(1–3)-β-D-glucans on the reduction 
of inflammation associated with the intestinal epithelial mucosa. 
However, the levels of TNF-α and IL-10 secreted by the tissues 
were not affected by the treatments. This lack of influence 
could be  due to the cytokine’s short lifespan and to the large 
number of proteases released by the tissue of CD patients 




FIGURE 1 | Evaluation of (1–3)-β-D-glucans in ex vivo model of inflamed gut mucosa. (A) The primary structure of EPS L and EPS M is depicted. (B) Organ culture 
assay, the tissues were collected from Crohn’s disease (CD) patients and incubated in the culture medium for 4 h. Then, the media were used to perform ELISA 
Immunoblot. (C) Concentration of tumor necrosis factor-α (TNF-α), IL-10, and IL-8 secreted by the tissues represented in Barplot mean with SEM. The levels of 
cytokines were quantified by the ELISA immunoblot method. Data passed the Kolmorov-Smirnov normality test, and statistical significance was tested with two 
tailed t-test between each treatment and control (Ctrl). IL-8 was decreased in inflamed tissue treated with EPS L p < 0.03 (*), EPS P p < 0.0068 (**), and laminarin 
p < 0.0097 (**) vs. untreated control.
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apply for the results obtained for IL-8, since the levels detected 
for this cytokine were 40 times higher than those observed 
for the TNF-α and IL-10. Therefore, the alteration of IL-8 
concentration seems to reflect the biological status of the tissue. 
One of the CD patients, whose ileocolonic biopsy was analyzed 
and previously treated with antibiotic (Table  2). Therefore, the 
results obtained could have a bias due to the inclusion of his 
biopsy in the study. However, quantification of the cytokine 
levels released by the biopsies of only the three other patients 
provided the same kind of pattern and behavior 
(Supplementary Figure S1), validating the performed assay.
Effect of O2-Substituted-(1–3)-β-D – 
Glucans on Gene Expression Profiling in 
ex vivo Model
To understand the immunomodulatory effect of the bacterial 
β-glucan on gene expression in the ex vivo model, levels of 
transcription of the TSLP, IL-8, IL-12p35, and NFκB coding 
genes in the treated vs. untreated tissues were determined by 
means of qPCR (Figure  2).
The analysis of gene expression in the treated vs. untreated 
tissues revealed in general a similar pattern of response to 
the exposure to EPS L, EPS P, or laminarin. Thus, the 
treatment with any of the three β-glucans resulted in a 
decrease of TSLP and IL-8 transcription. However, this effect 
was only statistically significant (p  =  0.0367) for TSLP in 
tissues treated with EPS P. TSLP is a protein, which belongs 
to the cytokine’s family and, that promotes T cell maturation 
when antigen presenting cells are activated. In IBD patients, 
low levels of TSLP are associated with a permeability increase 
of the gut barrier, or Th2 cell differentiation, depending on 
the cell type that is expressing it (epithelial cells or DC 
cells; Biancheri et  al., 2016; Park et  al., 2017). Recently, it 
has been proposed that TSLP also participate in Treg cell 
development and gut homeostasis perpetuation (Tahaghoghi-
Hajghorbani et  al., 2019). Our results suggest that EPS L 
and laminarin exhibit normal values of gene expression, 
leading to a balanced TSLP function, while EPS P slightly 
decreases its expression, and probably has no effect on TSLP 
turn over. EPS P fold change reached 0.74, which means 
that the decrease of relative expression is not so dramatic 
as expected in CD patients with active inflammatory reactions 
(Tahaghoghi-Hajghorbani et  al., 2019).
Our results also revealed that the NFκB transcript was 
over-expressed in tissues exposed to EPS L or laminarin 
(Figure  2). NFκB is a transcription factor that regulates the 
expression of pro-inflammatory genes, including cytokines, 
chemokines, and other molecules. NFκB is a heterodimer 
formed by RelA/1 that activates the canonical signaling pathway 
and Rel B/NFKB2 that activates the non-canonical pathway 
(see details in Figure  3). The first is activated by TNF-α or 
IL1, while the latter is activated by cluster differentiation 40 
(CD40), B cell activating factor, and other molecules, but not 
by TNF-α. The heterodimer activation mechanism is complex; 
additionally, the presence of cofactor molecules in the nucleus, 
that bind to the transcription factor complex, may influence 
the transcription of pro- or anti-inflammatory proteins coding 
genes (Lawrence, 2009). Its activity is regulated by the endogenous 
cytoplasmic inhibitors IκKs kinases complex that ensures the 
activation/repression of the heterodimer, that in specific 
conditions is able to transmigrate to the nucleus and induce 
transcription (Jobin and Sartor, 2000). In IBD, the canonical 
pathway is activated constitutively, thus conspicuous amounts 
FIGURE 2 | (1–3)-β-D-glucans modulate the relative gene expression of the biopsies of patients affected by CD. Barplot representation mean with SEM of TSLP, 
NFκB, IL-8 IL-12p35, and IL-10. Gene expression was analyzed by quantitative-RT-PCR (qPCR) analysis. Data passed the Shapiro-Wilk normality test, the unpaired 
two-tailed Student t-test was performed with Welch’s correction Only TSLP demonstrated a significance difference with a p < 0.03 vs. untreated control.
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of TNF-α are released by immune system cells in gut mucosa, 
as well as interferon-γ (IFN-γ) or IL-8 (Lawrence, 2009).
Our results indicate that EPS L and laminarin increased 
the relative expression of NFκB (RelA subunit) 1.5-fold higher 
than that of the control, while EPS P does not have any 
major effect. To comprehend the EPS effect on NFκB activation, 
it would be  necessary to study all genes involved in the 
NFκB signaling pathway and clarify EPS activity. We  would 
expect that the observed increase of NFκB expression would 
determine the increase of pro-inflammatory mediators, like 
IL-8 or TNF-α, instead we  detected the reduction of the 
IL-8 transcript (Figure  2) and no significant difference in 
TNF-α detection in cultured media (Figure  1), or in gene 
expression (Figure  2).
IL-8 is a chemokine produced by macrophages and intestinal 
epithelial cells (IEC); it is considered a good marker to 
determine disease activity (Mohammed Vashist et  al., 2018). 
It is also known as neutrophil chemotactic factor, because 
it induces chemotaxis in target cells such as neutrophils or 
other cells that migrate toward the infection focus (Llopis 
et  al., 2009; Walana et  al., 2018). Our results showed that 
the amount of the protein IL-8 (Figure 1) and the expression 
of its coding gene (Figure  2) decreased during treatments, 
suggesting that neutrophil recruitment also decreased as a 
consequence of the reduction of the inflammation rate. In 
line with these results, we  have previously detected that EPS 
P treatment decreased IL-8 and TNF-α expression in a 
gnotobiotic zebrafish larvae model, indicating its ability to 
reduce inflammation (Pérez-Ramos et  al., 2018). Also, when 
EPS P was tested in an induced inflammation model using 
the zebrafish transgenic line Tg(mpx:GFP)i114, a significant 
decrease of neutrophil recruitment to the inflammation focus 
was observed (Pérez-Ramos et  al., 2018).
Analysis of IL12p35 gene expression confirmed that the 
treatments did not augment the pro-inflammatory response in 
the ex vivo model (Figure  2). The fold change values were 
close to the untreated control, henceforth, taking into account 
that IL12p35 is the specific subunit of IL12 cytokine, EPS do 
not activate mechanisms involved in IL12 signaling pathway. 
Overall, the results obtained indicated a trend toward reduction 
of inflammation in CD biopsies treated with any of the three 
β-glucans.
IL-10 is an anti-inflammatory cytokine, that is released in 
the gut by macrophages and IEC to maintain homeostasis 
(Latorre et  al., 2018; Morhardt et  al., 2019). According to our 
results, IL-10 mRNA levels did not show significant differences 
in the expression profiling (Figure  2), confirming the results 
obtained in cytokine production (Figure  1). This agrees with 
our previous observation that macrophages derived from human 
monocytes treated independently with either EPS did not 
stimulate IL-10 production (Notararigo et al., 2014). Moreover, 
we observed the same behavior in a gnotobiotic zebrafish larvae 
model, where EPS P treatment did not result in an increase 
of IL-10 expression (Pérez-Ramos et al., 2018). Taken together, 
these results support that bacterial β-glucans do not interact 
with the IL10R receptor (Shouval et  al., 2014).
A B
FIGURE 3 | Effect of treatment with EPS L (A,B) or EPS P (B) on apoptotic signaling pathway. Adapted from Kyoto Encyclopedia of Genes and Genomes (KEGG; 
Kanehisa et al., 2014).
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Effect of EPS L and EPS P on the NFκB 
Gene Expression Profile of CD Patient 
Biopsy
After detecting IL-8 reduction at transcriptional and protein 
levels, as well as NFκB modulation, we  decided to investigate 
the effect of β-glucans on NFκB signaling pathways, carrying 
out a gene expression “array” with the RNA from the CD patient 
that showed the greatest IL-8 relative expression reduction. 
Moreover, to have a representative analysis, the results obtained 
for EPS treated and untreated samples were normalized taking 
in account the expression of three houskeeping genes (see details 
in “Materials and Methods”), and the results are depicted in 
Figure  4. The profiles in response to treatment with either EPS 
P or EPS L were, in general similar (Figures 4B–E). The expression 
of the cytokines IL1A and IL1B coding genes was reduced (fold 
change: IL1A 0.8, 0.7; IL1B 0.5, 0.8 for EPS L and EPS P 
treatment, respectively) as well as the levels of transcripts encoding 
the colony-stimulating factor 3 (CSF3) and the MyD88 adapter 
protein. These results point out that both EPS have an 
immunomodulatory effect on the gut immune system. Receptor 
Interacting Serine/Threonine Kinase 1 (RIPK1) was upregulated 
indicating a possible function in IEC, restoring the gut barrier 
integrity by preventing a dysregulated cell death mechanism. 
Moreover, the results seemed to support that the EPS selectively 
activated NFκB heterodimers, EPS P RelB/NFKB2, and EPS L 
RelA/NFKB1 (Figure  4A; Jobin and Sartor, 2000).
We selectively studied the NFκB heterodimer complex formed 
by RelB/NFKB2 and RelA/NFKB1 because NFκB1 and NFκB2 
act as inhibitors, blocking transcription factor translocation to 
the nucleus until an external stimulus activates the proteolysis 
that converts them into p50 and p52, respectively. The 
overexpression of both inhibitors, showed in Figure  4D, could 
be the key for the immunomodulatory effect of bacterial β-glucan.
According to these results, EPS P seemed to exert its impact 
mainly on the MyD88 independent signaling pathway, as shown 
by its influence on RelB, Interleukin 1 Receptor Associated 
Kinase 1 (IRAK1), RIPK1, Inhibitor of Nuclear Factor Kappa 
B Kinase Subunit Epsilon (IKBKE), Signal Transducer and 
Activator of Transcription 1 (STAT1), and CD40 (Figures 4C,D).
On the other hand, EPS L could modulate both the canonical 
and non-canonical pathways (Figure  4A). The first, MyD88 





FIGURE 4 | Effect of EPS P and EPS L on expression of genes involved in NFκB pathway. (A) NFκB heterodimers activate canonical and non-canonical pathway.  
(B), (C), (D), and (E) Expression profiling of representative genes (fold change),  whose expression resulted affected by the treatment. Data of the patient who showed 
the lower qPCR for IL-8.
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not shown), and RIPK1, and repressing IL1A and IL1B gene 
expression. The latter, MyD88 independent, by activation IKBKE 
and STAT1 (Figure 4C). In line with these findings, our previous 
results demonstrated that EPS P downregulated the relative 
expression of three genes involved in inflammation, MyD88 
among them, in a zebrafish larvae model, pointing out the 
potential of the O2-substituted-(1–3)-β-D-glucan as an 
immunomodulator (Pérez-Ramos et  al., 2018).
Although EPS P and EPS L could have a different effect 
on transduction pathways activated by NFκB, this analysis does 
not fully clarify what mechanisms they may be  modulating. 
Both have been shown to reduce the expression of 
pro-inflammatory cytokines, such as IL-1A, IL-1B, TNF, and 
IL-8 (Figure  4B), and these results have been validated in 
different models (Notararigo et  al., 2014; Pérez-Ramos et  al., 
2018). The overall results were quite complex, considering that 
many of the genes studied are involved in the signaling of 
different receptors and are present in the majority of cell types 
isolated in the CD biopsy. For this reason, it was necessary 
to use bioinformatics tools to group the genes whose function 
may be related, and improve the understanding of the mechanisms 
underlying the stimulus provided by the O2-substituted-(1–3)-
β-D-glucan, as described below.
Functional Analysis With David 
Bioinformatic Resources
In order to interpret the results of the differential response 
caused by each EPS on the tissue of the CD patient, a 
bioinformatic clustering with DAVID was carry out. The aim 
of this analysis was to arrange genes and derive their biological 
meaning, by association with identical or related functions 
and/or pathways. We  restricted gene analysis to fold changes 
between ≤5 and/or ≥1.5, to establish strong interaction between 
selected genes.
The gene clustering revealed a modulation of 14 or 19 
genes upon treatment with either EPS L or EPS P. Among 
the regulated genes, the presence of EPS L resulted in a 
reduction of expression of 4, whereas downregulation of only 
one gene was observed with the EPS P treatment. Also, 10 
or 19 where upregulated after exposure of the tissues to EPS 
L or EPS P, respectively. Furthermore, as a response to both 
treatments, the alteration of expression of five genes showed 
the same pattern: upregulation for IKBKE, PC4, and SFRS1 
interacting protein 1 (PSIP1), RIPK1 and STAT1, and 
downregulation for Colony-Stimulating Factor 3 (CSF3).
The functional analysis for molecular function of GO depicted 
in Table  3 showed that the enrichment in functional terms 
for genes affected by treatment with EPS P, was greater than 
that with EPS L in number, degree of enrichment, and number 
of members in each category. In addition, EPS L regulon 
included genes grouped into two categories related to cytokine 
activity, while for EPS P regulon more grouping terms were 
found, highlighting the regulation of caspase activity and 
cytokine activity. These results confirmed the data obtained 
from functional grouping (data not shown), and the overall 
results allowed us to postulate a possible mechanism of action 
of either EPS on the apoptosis pathway represented in Figure 3. 
EPS L could affect extrinsic apoptosis pathways with the 
inhibition of Tumor Necrosis Factor Apoptosis-Inducing Ligand 
10 (TNFSF10) and IL-1B, while also it could activate survival 
pathway (RIPK1), with a possible healing effect on gut barrier, 
through the NFκB pathway and chemotaxis reduction upon 
CSF3 downregulation. EPS P could activate apoptosis pathway 
by altering gene expression of Tumor Necrosis Factor Receptor 
Superfamily Member 10a (TNFRSF10A), and the cell death 
regulator BCL2L1 while repression of CSF3 may points to a 
role in modulation of intestinal immunity, with a possible 
decrease in the chemotaxis of the neutrophils to the foci of 
inflammation (Carol et  al., 2006).
To support this hypothesis, some of the results depicted in 
Figure  4E should be  discussed in the context of the apoptotic 
signal pathways. BCL2A1 is a gene which belongs to the BCL-2 
family, the protein encoded by this gene is able to reduce the 
release of pro-apoptotic cytochrome c from mitochondria and 
block caspase activation. The gene showed a 1.7- or 0.9-fold 
change upon treatment with EPS L or EPS P. This gene is 
directly activated by NFκB in response to inflammatory mediators, 
such as granulocyte-macrophage colony-stimulating factor 
(GM-CSF), CD40, and cytokine like TNF-α or IL-1 which 
suggest lymphocyte activation/proliferation and cell survival. 
Yet, both EPS downregulate TNF-α, IL-1A, and IL-1B, and 
have no effect on GM-CSF (data not shown), while only EPS 
P upregulated CD40. Taken together, these results suggest that 
EPS L had an anti-apoptotic effect, while EPS P had a possible 
pro-apoptotic effect. Indeed, both β-glucans showed an anti-
inflammatory effect, because of reduction of the relative 
expression of cytokines, that might reflect in reduced lymphocyte 
activation for EPS L and in cell death activation for EPS P.
The BCL2L1 gene product is a potent pro-apoptotic activator, 
and this gene was upregulated by both EPS treatments with 
a fold change of 1.6 for EPS P and 1.2 for EPS L. We postulate 
that the O2-substituted-(1–3)-β-D-glucans might reestablish 
normal condition of the intestinal immune system cells through 
an apoptosis activation mechanism (Figure  3B).
In addition, expression of the cytokine TNFSF10 was 
downregulated in the presence of both EPS (fold change: 0.5 
and 0.4 for EPS P and EPS L treatments, respectively) while 
TNFRSF10A, that binds TNFSF10 was slightly upregulated 
under EPS P treatment (fold change 1.3), and downregulated 
upon exposure to EPS L (fold change: 0.7). Moreover, Tumor 
Necrosis Factor Receptor Superfamily Member 10b (TNFRSF10B), 
and IL-1R receptors coding genes were downregulated (fold 
change: 0.9 and 0.7, respectively) in EPS L treated tissues, 
and upregulated (fold change: 1.4 and 1.7, respectively) in 
tissues exposed to EPS P (Figures 4B,C). These results indicate 
that EPS L and EPS P reduced the expression of the apoptotic 
ligand TNFSF10, but had a different effect on the expression 
of receptor TNFRSF10B, an IL-1R. It is possible that EPS P 
activates a cell death mechanism, to regulate lymphocyte 
proliferation, while EPS L acts at the cell mediation level by 
reducing cytokine production.
Therefore, EPS P seems to modulate apoptosis, as several 
results previously collected support the bioinformatic analysis. 
Some examples are, the lowering of IL-8  in an ex vivo model, 
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a zebra fish model and in an in vitro transwell model 
(unpublished data). The decreased level of IL-1B and IL12p35 in 
LPMCs isolated from CD biopsies and treated with either 
EPS, detected with Luminex (data not shown). IL-8 takes 
part in the neutrophil recruitment, while IL-1B and IL-12p35 
are Th1 mediators that augment when Th1 cells are deregulated, 
therefore indicating a possible implication of physiological 
modulation of apoptosis in these T cells subpopulations. It 
is well-established that IBD pathogeneses determines Th1/Th2 
imbalance toward Th1 (Neurath, 2014). Th1 proliferation is 
decontrolled because apoptosis regulation is imbalanced, 
increasing inflammation and chemotaxis in the gut. Hence, 
Th1 cells overproduce pro-inflammatory mediators like: TNF-α, 
IL1A, IL1B, IFN-γ etc. In turn TNF-α, that has a pivotal role 
in the mucosal inflammation, recruit, and over stimulate 
immune system cell like Th1.
Our data suggest that apoptosis intrinsic pathway mechanism 
(Stevens and Oltean, 2019), or in ameliorating gut barrier 
inflammation (Lu et  al., 2020), could be  re-established after 
O2-substituted-(1–3)-β-D-glucan administration, due to the fact 
that Bcl2 genes are overexpressed (Figure  4). According to that, 
Th1 proliferation could be  regulated and therefore reducing 
proinflammatory cytokine production’s (Figures  1C, 2, 4E).
As IBD is Th1 shifted pathology, and EPS P is able to 
ameliorate the rate of inflammation, it is plausible to postulate 
that it could play a role in Th1 through apoptosis modulation. 
Bioinformatic analysis revealed that many mediators of this 
pathway have been modulated by the treatment (Table  3), and 
we  also observed a reduction of pro-inflammatory mediators 
(Figures  1C, 2). As the Th1 of CD patients cycles faster than 
the healthy controls (Sturm et  al., 2004), it is fair to believe 
that Th1 could play a role in the re-establishment of Th1 
population to a normal concentration, and therefore lowering 
inflammation rate.
Regarding EPS L, gene clustering showed a dual behavior, 
by the reduction of cell death ligands expression such as 
TNFSF10 and IL-1B, and over-expression of RIPK, a kinase 
involved in necroptosis and cell survival, by modulating 
dysregulated apoptosis in IEC (Figure  3A; Dannappel et  al., 
2014). Thus, the EPS treatments affect mechanisms that restore 
gut burrier homeostasis due to its wound healing properties 
and reduce inflammation mediators.
It is worth noting that the differential response of the tissues 
to EPS P and EPS L might be  related to their structural 
differences. EPS P has a molecular mass of 9.6  ×  106  Da, 
higher than that of EPS L (6.6  ×  106  Da, Werning et  al., 
2014), that could increase the affinity of the natural 
O2-substituted-(1–3)-β-D-glucan (EPS P) affinity for its 
receptor(s). It has been shown that molecular mass and tertiary 
structure of β-glucans, play a critical role in receptor binding 
(Legentil et  al., 2015). We  have previously shown that EPS P 
increases adhesion of P. parvulus 2.6 to human enterocytes in 
vitro and increases in vivo the colonization capacity of the 
bacterial strain in the zebrafish gut (Pérez-Ramos et  al., 2018). 
Therefore, it is tempting to assume that, after ingestion in a 
beverage, P. parvulus 2.6 could synthesize EPS P in the human 
intestine and the action of glycosidases synthesized by the 
microbiota could reduce its molecular mass generating an EPS 
L-like polymer with its detected dual role.
CONCLUSION
In an ex vivo model of CD biopsies, treatment with EPS P 
and EPS L are concomitant with decreased levels of 
pro-inflammatory cytokine IL-8  in the supernatant of tissue 
biopsies, and in relative gene expression. RNA array demonstrated 
that O2-substituted-(1–3)-β-D-glucans modulate the NFkB 
pathway, activating both the canonical and non-canonical 
pathway. The differences found in the expression profiling 
indicate that the 9.6  ×  106  Da EPS P may be  able to restore 
the apoptosis mechanism in Th1 cells, whereas the 6.6 × 106 Da 
EPS L might restore the intestinal barrier through activation 
of RIPK1  in IEC. Further studies have to be  performed to 
determine which receptor is activated by EPS P and EPS L 
and, if a co-receptor is necessary for receptor recognition, and 
if EPS have different effects on immune system cells.
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TABLE 3 | Molecular function gene ontology (GO) terms for the gene differentially expressed upon EPS P or EPS L treatment.
GO TERM ENRICHMENTa GENES
EPS P GO:0043028~caspase regulator activity 47,12 TNFRSF10A, BCL2L1
GO:0005125~cytokine activity 10,51 CSF3, CCL2, and CSF1
GO:0004674~protein serine/threonine kinase activity 7,94 IRAK1, IKBKE, MAP3K1, RIPK1, and RAF1
GO:0004672~protein kinase activity 6,76 IRAK1, IKBKE, CCL2, MAP3K1, RIPK1, and RAF1
GO:0008134~transcription factor binding 5,33 TNFRSF10A, RELB, BCL3, and NFKB2
GO:0019899~enzyme binding 5,23 CSF3, IRAK1, MAP3K1, and CD40
GO:0042802~identical protein binding 4,27 IRAK1, MAP3K1, CSF1, and BCL2L1
GO:0003700~transcription factor activity 3,50 RELB, IRF1, BCL3, NFKB2, and STAT1
GO:0030528~transcription regulator activity 2,71 IRAK1, RELB, IRF1, BCL3, NFKB2, and STAT1
EPS L GO:0032813~tumor necrosis factor receptor superfamily binding 64,43 TNFSF10, RIPK1
GO:0005125~cytokine activity 20,49 CSF3, TNFSF10, IL1B, and CCL5
aEnrichment of functional terms is shown as a proportion. It represents the gene list input divided by all the genes annotated to the selected GO term.
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